By LegitScript Folks
on March 27, 2023
Before 2020, when the pandemic limited access to in-person healthcare, telehealth was growing only incrementally and some well-meaning laws made it difficult to access certain medications. Now, newly proposed federal rules take into account how society has changed in a post-COVID world, and how it’s impacted the prescribing of controlled substances online. Read more to understand what new rules the DEA is proposing, and their potential to permanently change the telemedicine landscape.
on March 22, 2023
LegitScript is here to shine a light on one of the most noteworthy cannabinoids currently marketed online — delta-8 THC. Read this expanded-on excerpt from Top 10 High-risk Trends That Put You at Risk of BRAM and GBPP Fines to understand what delta-8 THC is, and why you should watch out for it.
By David Khalaf
on March 20, 2023
Inside Look: LegitScript Merchant Monitoring Learn all about our best-in-class solution and see if it's right for you and your risk and compliance team. Session Dates Dates and Times We get a lot of questions about LegitScript's best-in-class Merchant Monitoring solution: How does it work? What are its features? What makes it different from other…
By Thea Le Fevre
on March 10, 2023
LegitScript’s Associate General Counsel, Gerard Olson, takes a deep dive into the regulatory landscape of cannabis, marijuana, and CBD. Read more to understand the regulatory landscape of these products, recent stances the FDA has taken, and what problematic products we’re finding online.
on March 06, 2023
Bad actors may change their methodologies as technology evolves, but the same offerings emerge year after year. In this recap of LegitScript’s recent webinar, we identify and track seasonal high-risk trends in payment processing and on e-commerce platforms to help you anticipate them. Read more to understand what these trends are and how to grow your business more confidently.
on February 13, 2023
These three (and free) one-hour webinars take a deep dive into the regulatory landscape of rapidly evolving high-risk industries. Are you a professional in payments risk & compliance or internet trust & safety? Read more to understand why you should register.
on August 08, 2022
On recent news that the White House is exploring the possibility of creating a federal task force to “explore the potential of psychedelic-assisted therapies” in the United States, certain psychoactive substances seem to be having a moment. Public awareness of these substances appears to be increasing in tandem with government interest; take, for example, the…
on June 29, 2022
In this episode of Banned Buys, we unbox taffy made with kratom (Mitragyna speciosa), a Drug of Concern often marketed as an opioid withdrawal aid. Our expert explains the effects of kratom, what people use kratom for, whether kratom is addictive, and laws and regulations around kratom. Learn more.
on May 16, 2022
Earlier this month, the U.S. Food and Drug Administration (FDA) for the first time issued warning letters regarding products that contain delta-8 THC. Letters were issued to five companies that were marketing products labeled as containing delta-8 THC in ways that, according to the FDA, violate the Federal Food, Drug, and Cosmetic Act (FDCA). Additionally,…
on March 10, 2022
Learn about common psychoactive substances for sale online and the legal approaches them in the United States. Download the guide now.